NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Claritas Rx

Claritas Rx

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.claritasrx.com/

Last Round

Series A

Mar 9, 2021

Total Funding Raised

$32.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Claritas Rx is a healthcare technology company that provides a data integration and analytics platform designed for biopharmaceutical manufacturers to track specialty drug performance and patient journeys.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Patient Engagement, Pharma Supply Chain, Data Integration, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

specialty pharmacy datapatient journey analyticsbiopharma SaaSpatient hubpharma CRMpatient servicespharma techmarket accessdata integrationpatient support softwarepatient adherencepredictive risk scoringNBAnext best actionpatient consent managementcommercial analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Claritas Rx Comparables

Compare Claritas Rx with similar companies based on industry and business-model similarity.

Claritas Rx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ConcertAI
84%
Prospection
79%
IntegriChain
79%

Claritas Rx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 9, 2021
Series AFeb 1, 2021
SeedJul 1, 2020
DebtApr 16, 2020

Key People

Founding team and executive leadership

Kevin Donalds

Chief Financial Officer

Executive Team

Ranjan Dutta

Chief Financial Officer

Executive Team

Scott L Earl

Chief Financial Officer

Executive Team

Claritas Rx Investors

Notable investors and investment history

Claritas Rx investors
InvestorRounds
Questa CapitalSeries A
Kiplin CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 103% MoM, reaching 12.2K.

  • Apr 20, 2026

    Launched Omnichannel CRM to transform patient services.

Claritas Rx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Claritas Rx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Claritas Rx's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range130
Year Founded2011
Last FundingMar 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.